Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

extracellular

extracellular is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 5
News articles 0
Drug details — extracellular
Class
—
Route
—
Patents
20
Programs
5
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

extracellular is an FDA-listed pharmaceutical active ingredient.

Key facts

INN extracellular

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. COOPERATION 2.0 Phase 2 · Telethon Foundation · Patients with connective tissue diseases at high risk of int
  2. ACE001-RI001 Phase 1 · ZhongShan Hospital, Fudan · Interstitial Lung Disease (ILD)
  3. APHP200034 Phase 1 · PARItec · Non-ischemic Dilated Cardiomyopathies
  4. Extracellular Vesicles from Mesenchymal Stem Cells Phase 1 · Regeneron Ireland Designated · COVID-19 Pneumonia
  5. Tolvaptan Approved · Otsuka Beijing Research · Hyponatremia and Extracellular Fluid in Cirrhotic

Related patents

Browse patents

  1. US 12365719

    CD80 extracellular domain polypeptides and their use in cancer treatment

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12090175

    Compositions and methods for tissue repair with extracellular matrices

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12017066

    Modulation of extracellular vesicles with electrical stimulation

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11998635

    Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11801268

    Methods of treating ocular inflammation and chemical injuries of the eye with extracellular vesicles

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11786635

    Extracellular matrix for treating pelvic floor disorders and skeletal muscle degeneration

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11717480

    Extracellular vesicles and methods and uses thereof

    Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11491115

    Nanoparticles containing extracellular matrix for drug delivery

    Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11459593

    Dendrobium officinale endophytic fungus strain and extracellular polysaccharide produced thereby, and extraction method and application of extracellular polysaccharide

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11376346

    Extracellular matrix for treating pelvic floor disorders and skeletal muscle degeneration

    Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11191780

    Extracellular matrix compositions for the treatment of cancer or immunological diseases

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11098103

    CD80 extracellular domain polypeptides and their use in cancer treatment

    Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11016009

    Method for isolating extracellular vesicles using aqueous two-phase system

    Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10946047

    Extracellular vesicles with enhanced potency

    Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10695293

    Method of preventing or treating radiation-induced dermatitis with extracellular vesicles

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10675303

    Extracellular matrix compositions for the treatment of cancer

    Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10624849

    Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites

    Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10392618

    Micro-RNA family that modulates extracellular matrix genes and uses thereof

    Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10273281

    CD80 extracellular domain polypeptides and their use in cancer treatment

    Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10265396

    Magnetic extracellular matrix

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is extracellular?

extracellular is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.